Skip to main content
. 2015 Apr 1;35(3):288–297. doi: 10.3343/alm.2015.35.3.288

Fig. 2. Comparisons of overall survival and disease free survival in core binding factor acute leukemia patients with t(8;21) and no FLT3 ITD or NPM1 mutations, among four patient subgroups categorized by c-KIT and WT1 mutation status (N=58, A, overall survival; B, disease free survival).

Fig. 2

Abbreviation: WT, Wilms' tumor.